Clinical Insights Journal

Welcome to this New Resource

We are pleased to introduce a new publication designed for clinicians who are using the Child Bipolar Questionnaire (CBQ) and J/J tools to serve children and adolescents affected by bipolar disorder and Fear of Harm (FOH*). Our goal is to share research, clinical insights, and practical strategies that can support your work with this challenging population.

With more than 3,000 clinical users worldwide, this community represents a powerful collective of knowledge and experience. Whether you have been utilizing these tools extensively or are just beginning to explore their potential, this publication is intended to strengthen your clinical practice, keep you informed as a practitioner, and connect you with a peer network of colleagues committed to advancing care for children with FOH/TSDD.

* Increasingly referred to asThermoregulatory Sleep Dysregulation Disorder (TSDD).

What's Ahead:

In upcoming issues, you can look forward to:

• Case Spotlights: Clinical vignettes, potentially from your own practice, illustrating how combining family therapy, cooling strategies and targeted pharmacotherapy (e.g., lithium, ketamine) has been applied with success—while preserving confidentiality.
• Practical Implementation Tips: Guidance on how to integrate recent findings into your existing CBQ and J/J assessment workflows.
• Research: Access to current studies that are deepening our understanding of the FOH/TSDD condition.
• Webinar Announcements: Upcoming sessions focused on diagnosis and treatment strategies for children with FOH/TSDD—including insights from recent research and discussion with expert clinicians.

Featured Research:

Treatment of Early-Onset Specified and Unspecified Bipolar Disorders: A Systematic Review and Strategies for Identifying and Managing a Thermally Dysregulated Subtype in Children

Published In: Acta Psychiatrica Scandinavica (April 2025)

In this peer-reviewed article:

1. Formal definition of the TSDD/FOH phenotype.

2. Systematic review of early-onset bipolar treatments, highlighting family-focused therapy as most effective, across nine RCTs.

3. Case series showing promising responses to lithium, clonidine, and ketamine..

4. Call for continued clinical innovation and research collaboration.

CLICK HERE TO READ THE STUDY

We Want Your Input:

Tell us what you would like to see addressed in this new resource. 

Click Here to share your thoughts

Sent by Juvenile Bipolar Research Foundation

Click here to unsubscribe from this list